From: Clinical relevance of SARS-CoV-2 infection in late pregnancy
Characteristics | Sars-Cov-2 infection | Controls | p |
---|---|---|---|
n = 28 | n = 287 | ||
Age (years) | 31.6 ± 7.0 | 34.2 ± 5.4 | 0.07 |
BMI (Kg/m2) | 27.1 ± 4.5 | 26.4 ± 4.2 | 0.41 |
Gestational age (weeks) | 38.8 ± 1.4 | 38.8 ± 2.0 | 0.79 |
Ethnicity | 0.08 | ||
Caucasian | 20 (71.4%) | 230 (80.1%) | |
Black / African | 2 (7.2%) | 26 (9.1%) | |
Asian | 0 (0.0%) | 9 (3.1%) | |
Hispanic | 6 (21.4%) | 22 (7.7%) | |
Smoking in pregnancy | 1 (3.6%) | 12 (4.2%) | 1.00 |
ART pregnancy | 1 (3.6%) | 22 (7.7%) | 0.71 |
Previous vaginal deliveries | 7 (25.0%) | 89 (31.0%) | 0.67 |
Previous cesarean sections | 5 (17.9%) | 45 (15.7%) | 0.79 |
Previous myomectomy | 0 (0.0%) | 5 (1.7%) | 1.00 |
Main medical complications | |||
Thyroid disorders | 0 (0.0%) | 22 (7.7%) | 0.24 |
Autoimmune disorders | 0 (0.0%) | 9 (3.1%) | 1.00 |
Cardiovascular problems | 2 (7.2%) | 6 (2.1%) | 0.15 |
Thrombophylia | 0 (0.0%) | 3 (1.0%) | 1.00 |
Respiratory disorders | 0 (0.0%) | 4 (1.4%) | 1.00 |
Others | 2 (7.2%) | 7 (2.4%) | 0.19 |
Multiple pregnancy | 1 (3.6%) | 10 (3.5%) | 1.00 |
Flu vaccination in pregnancy | 9 (32.1%) | 96 (33.4%) | 1.00 |